Clinical Trials for Epidermolysis Bullosa

Thera-Clean® Microbubbles System in Patients With Skin Diseases

NCT ID: NCT07050810

This clinical trial is testing a new treatment called Thera-Clean® Microbubbles, which uses tiny bubbles in water to help clean and heal skin affected by certain conditions like psoriasis, eczema (...

A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

NCT ID: NCT06917690

This clinical trial is exploring the safety and effectiveness of a new gel called Oleogel-S10 for treating skin wounds in people with a rare condition called epidermolysis bullosa (EB). Specificall...

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

NCT ID: NCT06834035

This clinical trial is looking at a new treatment approach for a rare skin condition called Recessive Dystrophic Epidermolysis Bullosa (RDEB), which causes painful skin blisters. The researchers wa...

Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling

NCT ID: NCT06330350

This clinical trial is focused on understanding the thoughts and needs of patients with specific skin conditions, known as genodermatoses, and their partners who want to have children. The study ai...

Reproductive Options in Inherited Skin Diseases

NCT ID: NCT06330324

Computational Drug Repurposing for All EBS Cases

NCT ID: NCT03269474

This clinical trial is studying a skin condition called Epidermolysis Bullosa (EB), which causes the skin to be very fragile and easily blistered. The researchers want to learn how the skin behaves...

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

NCT ID: NCT05838092

This clinical trial is investigating a new treatment for a skin condition called recessive dystrophic epidermolysis bullosa (RDEB), which causes very fragile skin that blisters easily. The treatmen...

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

NCT ID: NCT05464381

This clinical trial is looking at a new treatment for a skin condition called Epidermolysis Bullosa (EB), specifically a type known as recessive dystrophic epidermolysis bullosa (RDEB) and another ...